BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3098885)

  • 1. Dopaminergic inhibition of tyrosinase activity in hair follicular melanocytes of the mouse.
    Burchill SA; Thody AJ
    J Endocrinol; 1986 Nov; 111(2):233-7. PubMed ID: 3098885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocyte-stimulating hormone and the regulation of tyrosinase activity in hair follicular melanocytes of the mouse.
    Burchill SA; Thody AJ
    J Endocrinol; 1986 Nov; 111(2):225-32. PubMed ID: 3098884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocyte-stimulating hormone, tyrosinase activity and the regulation of eumelanogenesis and phaeomelanogenesis in the hair follicular melanocytes of the mouse.
    Burchill SA; Thody AJ; Ito S
    J Endocrinol; 1986 Apr; 109(1):15-21. PubMed ID: 3084696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alpha-melanocyte-stimulating hormone on tyrosinase activity in hair follicular and epidermal melanocytes of the mouse.
    Seechurn P; Burchill SA; Thody AJ
    J Endocrinol; 1988 Dec; 119(3):517-22. PubMed ID: 2851641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of tyrosinase synthesis and its processing in the hair follicular melanocytes of the mouse during eumelanogenesis and phaeomelanogenesis.
    Burchill SA; Virden R; Thody AJ
    J Invest Dermatol; 1989 Aug; 93(2):236-40. PubMed ID: 2502579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of melanocyte-stimulating hormone on tyrosinase expression and melanin synthesis in hair follicular melanocytes of the mouse.
    Burchill SA; Ito S; Thody AJ
    J Endocrinol; 1993 May; 137(2):189-95. PubMed ID: 8326247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of tyrosinase synthesis by alpha-melanocyte-stimulating hormone in hair follicular melanocytes of the mouse.
    Burchill SA; Virden R; Fuller BB; Thody AJ
    J Endocrinol; 1988 Jan; 116(1):17-23. PubMed ID: 2828505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-2 dopaminergic agonists and adenosine 3',5'-monophosphate directly regulate the synthesis of alpha-melanocyte-stimulating hormone-like peptides by cultured rat melanotrophs.
    Beaulieu M; Felder R; Kebabian JW
    Endocrinology; 1986 Mar; 118(3):1032-9. PubMed ID: 2419116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of tyrosinase in hair follicular melanocytes of the mouse during the synthesis of eumelanin and phaeomelanin.
    Burchill SA
    Ann N Y Acad Sci; 1991 Dec; 642():396-405; discussion 405-6. PubMed ID: 1667073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosinase activity in the first coat of agouti and black mice.
    Movaghar M
    Pigment Cell Res; 1989; 2(5):401-7. PubMed ID: 2511568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
    Menon MK; Gordon LI; Kodama CK; Fitten J
    Life Sci; 1988; 43(10):871-81. PubMed ID: 2901020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-tyrosinase inhibition of melanogenesis by melatonin in hair follicles in vitro.
    Logan A; Weatherhead B
    J Invest Dermatol; 1980 Jan; 74(1):47-50. PubMed ID: 6766170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
    Cho S; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
    Sweidan S; Edinger H; Siegel A
    Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M; Gershanik O; Stefano FJ
    Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
    Ichihara K; Nabeshima T; Kameyama T
    Eur J Pharmacol; 1993 Apr; 234(2-3):155-63. PubMed ID: 8097720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.